| human | Q5 |
| P269 | IdRef ID | 260082503 |
| P496 | ORCID iD | 0000-0002-3102-6778 |
| P1053 | ResearcherID | J-8410-2014 |
| P1153 | Scopus author ID | 35114773100 |
| P214 | VIAF ID | 42165322856316021479 |
| P69 | educated at | Cliniques universitaires Saint-Luc | Q2979314 |
| P108 | employer | Massachusetts General Hospital | Q126412 |
| National Fund for Scientific Research | Q2600910 | ||
| Cliniques universitaires Saint-Luc | Q2979314 | ||
| P735 | given name | Bernard | Q14649171 |
| Bernard | Q14649171 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q55333193 | A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER). |
| Q47784298 | Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults |
| Q47250658 | Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association |
| Q64926277 | An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults. |
| Q92621992 | Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer's disease diagnosis |
| Q33761290 | Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging |
| Q64900616 | Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. |
| Q64898974 | Association of anxiety with subcortical amyloidosis in cognitively normal older adults. |
| Q92851328 | Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid |
| Q51016275 | Associative encoding deficits in amnestic mild cognitive impairment: a volumetric and functional MRI study. |
| Q91523615 | Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred |
| Q46740778 | Cerebral lateralization of face-sensitive areas in left-handers: only the FFA does not get it right |
| Q48609740 | Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers |
| Q90412400 | Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults |
| Q48621788 | Decreased hippocampal metabolism in high-amyloid mild cognitive impairment |
| Q96818975 | Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study |
| Q34254072 | Defining face perception areas in the human brain: a large-scale factorial fMRI face localizer analysis |
| Q92286190 | Dementia, End of Life, and Euthanasia: A Survey Among Dementia Specialists Organized by the Belgian Dementia Council |
| Q38933111 | Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β. |
| Q48284478 | Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline |
| Q38673547 | Functional network integrity presages cognitive decline in preclinical Alzheimer disease |
| Q38829043 | Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals |
| Q30100986 | Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex |
| Q38851607 | Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden |
| Q48478156 | Increased sensitivity to proactive and retroactive interference in amnestic mild cognitive impairment: new insights |
| Q38377707 | Increased sensitivity to proactive interference in amnestic mild cognitive impairment is independent of associative and semantic impairment |
| Q47141267 | Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals. |
| Q50558815 | Investigating Associative Learning Effects in Patients with Prodromal Alzheimer's Disease Using the Temporal Context Model. |
| Q47658024 | Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults |
| Q50445931 | Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease |
| Q59544083 | PET staging of amyloidosis using striatum |
| Q48710914 | Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved |
| Q38479624 | Performance on the RI-48 Cued Recall Test Best Predicts Conversion to Dementia at the 5- and 10-Year Follow-Ups |
| Q38896981 | Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals |
| Q47863932 | Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer's Disease |
| Q47607239 | Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden |
| Q61452943 | Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia |
| Q60301491 | Regional tau pathology and loneliness in cognitively normal older adults |
| Q91329003 | Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults |
| Q59544086 | Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts |
| Q50556792 | Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease. |
| Q62492915 | Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity |
| Q63101708 | The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? |
| Q90484535 | The impact of amyloid-beta and tau on prospective cognitive decline in older individuals |
| Q55003402 | The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. |
| Q40983810 | Unirhinal Olfactory Testing for the Diagnostic Workup of Mild Cognitive Impairment |
| Q90628286 | Vascular Risk and β-Amyloid Are Synergistically Associated with Cortical Tau |
Search more.